Announcement of the Department of Disease Control, Ministry of Public Health, Thailand on the Public use of patent for Pharmaceutical Products

Patent Act of 11 March B.E. 2522 (1979) as amended by Act (No. 3) B.E. 2542 (1999). See section 51 for rules concerning compulsory licensing.

November 30, 2006. Interview with Dr. Suwit Wibulpolprasert, Senior Advisor on Health Economics, Ministry of Public Health, Thailand.

Decmber 18, 2006. James Love in the Huffington Post. Merck, USTR ask Thailand to Reconsider Compulsory License on AIDS Drug.

December 12, 2006. James Love of CPTech. Letter asking USTR not to interfere with the Thai government decision to issue a government-use license on patents covering the AIDS drug efavirenz.

January 16, 2007. Global Health Policy Blog on Congressional Support for Thai Compulsory License.

December 21, 2006. Sign-on letter to Condoleezza Rice, Secretary of State, and Ambassador Susan Schwab, United States Trade Representative, regarding pressures on Thailand for issuing a compulsory license for AIDS drug efavirenz.

December 19, 2006. Nicolas de Torrente, Executive Director of Medecins Sans Frontieres-USA, and Paul Cawthorn, Head of Mission, MSF-Thailand. Letter to US Secretary of State Condoleezza Rice and US Trade Representative Susan Schwab.

December 3, 2006. Brook Baker for Health GAP. Price Cut Handcuffs: Thailand Must Stand Up to Merck.

December 2, 2006. Op-ed by Paul Cawthorne (MSF) and Ashvin Dayal (Oxfam) for the Nation. Thailand still shows the way on HIV/Aids.

November 30, 2006. Medecins Sans Frontiers. MSF Welcomes Move to Oversome Patent on AIDS Drug in Thailand.

November 29, 2006. Thai Network of People Living With HIV/AIDS. Statement on the Compulsory License.

December 18, 2006. Sean Flynn, American University Washington College of Law, Program on Information Justice and Intellectual Property. Thai Law on Government Use Licenses.

December 1, 2006. Pharmaceutical Research and Manufacturers of America. Protecting Patent Rights in Thailand.

January 11, 2007. Mark Drajem for Bloomberg. Democrats Write USTR on Thailand Compulsory Licensing Dispute.

January 9, 2007. William L. Aldis for the Bangkok Post. OPINION: It could be a matter of life and death

January 5, 2007. Lancet editorial. Undermining TRIPS: protectionism at its worst.

December 30, 2006. David Sirota for the Huffington Post. Bush Values Life - Until His Donors Call.

December 29, 2006. Greg Hitt for the Wall Street Journal. Activists Tell Administration to Keep out of Thailand AIDS-drug Dispute. (scroll down)

December 26, 2006. Connie Levett for the Age. Thais locked in a battle for life.

December 24, 2006. Tove Iren S. Gerhardsen for IP-Watch. Thailand Compulsory License On AIDS Drug Prompts Policy Debate.

December 22, 2006. Tove Iren S. Gerhardsen for IPWatch. Thailand Compulsory License On AIDS Drug Prompts Policy Debate IPWatch.

December 19, 2006. Arthit Khwankhom for the Nation. Aids groups upset by amendments - HIV/Aids activists claim patent-law changes would allow drugs 'trickery.'

December 18, 2006. Marwaan Macan-Markar for the Inter-Press Service. Asian Govts Push Generic Drugs

December 13, 2006. Bridges Weekly Trade News Digest. Thailand Issues Compulsory License for Patented AIDS Drug.

December 13, 2006. Patent Baristas. Thailand Issues Compulsory License to AIDS Drug.

December 8, 2006. Inside U.S. Trade. PhRMA Criticizes Thailand compulsory License for HIV/AIDS Drug.

December 6, 2006. Xinhuanet. Thai ministry OKs AIDS drug patent license.

December 1, 2006. Chee Yoke Ling for TWN's South-North Development Monitor. Thailand issues compulsory licence for cheaper AIDS drug.

November 30, 2006. Darren Schuettler for Reuters. Activists hail Thai move to make generic AIDS drug.

November 29. 2006. Apiradee Treeretkuarkul for the Bangkok Post. Local version of new Aids drug planned.

November 29, 2006. Andrew Leonard for Salon. Why Thailand isn't smiling at Big Pharma.

August 22, 2006. Alan Beattie, Andrew Jack and Amy Kazmin for the Financial Times, London. Patent or patient? How Washington uses trade deals to protect drugs. Article posted by bilaterals.org.